Bliss GVS Pharma - Quaterly Results

02 May 2024 Evaluate
The company witnessed a 14.22% growth in the revenue at Rs. 1638.17 millions for the quarter ended March 2024 as compared to Rs. 1434.19 millions during the year-ago period.The Net Loss for the quarter ended March 2024 is Rs. -114.61 millions as compared to Net Profit of Rs. 61.05 millions of corresponding quarter ended March 2023Operating profit surged to 336.13 millions from the corresponding previous quarter of 173.90 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 1638.17 1434.19 14.22 6054.60 5983.40 1.19 6054.60 5983.40 1.19
Other Income 84.64 64.79 30.64 335.01 507.66 -34.01 335.01 507.66 -34.01
PBIDT 336.13 173.90 93.29 1406.68 1409.21 -0.18 1406.68 1409.21 -0.18
Interest 15.31 49.73 -69.21 58.06 100.56 -42.26 58.06 100.56 -42.26
PBDT -90.04 124.17 -172.51 937.76 1308.65 -28.34 937.76 1308.65 -28.34
Depreciation 62.29 39.74 56.74 235.19 151.73 55.01 235.19 151.73 55.01
PBT -152.33 84.43 -280.42 702.57 1156.92 -39.27 702.57 1156.92 -39.27
TAX -37.72 23.38 -261.33 196.13 302.14 -35.09 196.13 302.14 -35.09
Deferred Tax -97.62 -24.68 295.54 -75.49 -42.10 79.31 -75.49 -42.10 79.31
PAT -114.61 61.05 -287.73 506.44 854.78 -40.75 506.44 854.78 -40.75
Equity 104.69 104.15 0.52 104.69 104.15 0.52 104.69 104.15 0.52
PBIDTM(%) 20.52 12.13 69.22 23.23 23.55 -1.35 23.23 23.55 -1.35

Bliss GVS Pharma Share Price

155.90 2.20 (1.43%)
22-Jan-2026 13:21 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1617.10
Dr. Reddys Lab 1221.05
Cipla 1376.10
Zydus Lifesciences 884.40
Lupin 2177.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×